Low incidence of kidney rejection after simultaneous kidney-pancreas transplantation after antithymocyte globulin induction and in the absence of corticosteroids: Results of a prospective pilot study in 28 consecutive cases

Transplantation

Volumn 69, Issue 7, 2000, Pages 1505-1508

  Cantarovich, Diego ^a   Giral Classe, Magali ^a   Hourmant, Maryvonne ^a   Dantal, Jacques ^a   Blancho, Gilles ^a   Karam, Georges ^a   Soulillou, Jean Paul ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG TOLERABILITY; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; MALE; PANCREAS TRANSPLANTATION; PILOT STUDY; PRIORITY JOURNAL; SERUM SICKNESS;

EID: 0034655376     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200004150-00051     Document Type: Article

References (12)

1. Sutherland DER. Pancreas and pancreas-kidney transplantation. Curr Opin Nephrol Hypertens 1998; 7: 317.
2. Klauser R, Muhlbacher F, Gnant M, et al. Pancreatic transplantation with venous portal drainage. Lancet 1989; 2: 988.
3. Diem P, Abid M, Redmon JB, Sutherland DE, Robertson RP. Systemic venous drainage of pancreas allograft as independent cause of hyperinsulinemia in type I diabetic recipients. Diabetes 1990; 39: 534.
4. Giral-Classe M, Hourmant M, Cantarovich D, et al. Delayed graft function of more than six days strongly decreases long-term survival of transplanted kidneys. Kidney Int 1998; 54: 972.
5. Cantarovich D, Le Mauff B, Hourmant M et al. Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody: I. Results following combined pancreas and kidney transplantation. Transplantation 1994; 57: 198.
6. Cantarovich D, Paineau J, Karam G, et al. Definitive corticosteroid withdrawal following simultaneous pancreas and kidney transplantation. Transplant Proc 1991; 23: 1583.
7. Cantarovich D, Karam G, Giral-Classe M, et al. Randomized comparison of triple therapy and antithymocyte globulin induction treatment after simultaneous pancreas-kidney transplantation. Kidney Int 1998; 54: 1351.
8. Gruessner RWG, Sutherland DER, Drangsveit MB, Wrenshall L, Humar A, Gruessner AC. Mycophenolate mofetil in pancreas transplantation. Transplantation 1998; 66: 318.
9. Gruessner RWG. Tacrolimus in pancreas transplantation: a multicenter analysis. Clin Transplant 1997; 11: 299.
10. Stegall MD, Simon M, Wachs ME, Chan L, Nolan C, Kam I. Mycophenolate mofetil decreases rejection in simultaneous pancreas-kidney transplantation when combined with tacrolimus or cyclosporine. Transplantation 1997; 64: 1695.
11. Birkeland SA. Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy. Transplantation 1998; 66: 1207.
12. Genestier L, Fournel S, Flacher M, Assossou O, Revillard JP, Bonnefoy-Berard N. Induction of Fas (Apo-1, CD95)-mediated apoptosis of activated lymphocytes by polyclonal antithymocyte globulins. Blood 1998; 91: 230.